Standard BioTools

📍 South San Francisco, United States👥 542 employees💰 Last funded Apr 2022
Biotechnology Research🌐 standardbio.com
Website LinkedIn
Fluidigm is now Standard BioTools. A company and a name that reflects our commitment to you and your research … To unleash the power of essential, standardized tools that help the life science industry develop breakthrough medicines faster and better. We are evolving to better meet the needs of our customers, bridging a robust and established portfolio of next-generation technologies with an experienced team of leaders dedicated to operational excellence. Standard BioTools – Unleashing reliable tools to accelerate breakthroughs in human health • Providing trusted and repeatable insights that transform scientific discoveries into better outcomes • Improving operating systems through more focused, methodical and consistent processes and an emphasis on quality • Delivering important value to our customers and their research
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2009–2022 · investors recorded per year
200912019120221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Standard BioTools?
Standard BioTools has 3 investors on record on gritt.io.
When did Standard BioTools last raise funding?
The most recent investment in Standard BioTools recorded on gritt.io was in April 2022.
What industry is Standard BioTools in?
Standard BioTools operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Standard BioTools based?
Standard BioTools is headquartered in South San Francisco, United States.